HAR1A and Alzheimer disease: Finally, in a study focusing on the network of miRNA sponges for various neuropsychiatric disorders, including autism, HAR1A was identified as a candidate for this role in the autism spectrum disorder (Balasubramanian and Vinod, 2022) and was also found to be downregulated in AD (Li and De Muynck, 2021).